- I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
- I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers
- I-Mab to Participate at the Jefferies Global Healthcare Conference
- I-MAB Filed 2023 Annual Report on Form 20-F
- I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
- I-Mab Announces Closing of the Divestiture of Business Operations in China
More ▼
Key statistics
On Wednesday, I-Mab (IMAB:NMQ) closed at 1.85, 59.48% above the 52 week low of 1.16 set on Sep 25, 2023.
52-week range
Open | 1.84 |
---|---|
High | 1.89 |
Low | 1.83 |
Bid | 1.86 |
Offer | 1.88 |
Previous close | 1.85 |
Average volume | 482.11k |
---|---|
Shares outstanding | 80.88m |
Free float | 69.87m |
P/E (TTM) | -- |
Market cap | 150.44m USD |
EPS (TTM) | -2.43 USD |
Data delayed at least 15 minutes, as of Jun 12 2024 21:00 BST.
More ▼